|
| Project Description |
| Flow Diagrams |
| Contact Information |
| Consortium Members |
| Diseases Under Investigation |
|
* Chagas' Disease [American Trypanosomiasis] |
|
* African Sleeping Sickness [African Trypanosomiasis] |
| * Leishmaniasis |
| * Malaria |
| Target Organisms |
| * Trypanosoma cruzi |
| * Trypanosoma brucei |
| * Leishmania spp. |
| * Plasmodium falciparum |
| * (Plasmodium vivax) |
| Genome Status |
| SGPP Progress |
| Papers by SGPP |
| Related Links/Resources |
| Employment Opportunities |
| SGPP News Articles |
| Feedback on SGPP web site |
|
|
MALARIA
Malaria (Plasmodium falciparum) has the potential to infect more than 40% of the world's population! One-hundred countries are reported with endemic transmission. The annual incidence ranges from 300 to 500 million; and, this high morbidity proves to be a drain on economics. Current World Health Organization (WHO) estimates report 1.5-2.7 million deaths from malaria per year. Most of the victums are young (less than five years old) African children. Vaccines are highly unlikely due to antigenic variation and the parasite's resistance to drugs has proved to be a huge problem.
General Information: Medline, World Health Organization |
